| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/06/2001 | CA2410543A1 Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens |
| 12/06/2001 | CA2410516A1 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers |
| 12/06/2001 | CA2410436A1 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 12/06/2001 | CA2410051A1 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes |
| 12/06/2001 | CA2409932A1 Combination of a mutant herpes virus and a chemotherapeutic agent for the treatment of cancer |
| 12/06/2001 | CA2401974A1 Dna expression vectors and methods of use |
| 12/06/2001 | CA2383432A1 Therapeutic immune condition compositions and methods |
| 12/05/2001 | EP1160323A1 5T4 tumour-associated antigen for use in tumour immunotherapy |
| 12/05/2001 | EP1160256A2 Monoclonal antibody specific for beta-A4 peptide |
| 12/05/2001 | EP1160255A1 Monovalent antibody fragments |
| 12/05/2001 | EP1159969A1 Composition vaccinale |
| 12/05/2001 | EP1159968A1 Attenuated strains of Dengue virus and their use in a vaccine composition |
| 12/05/2001 | EP1159967A1 Tumor vaccines |
| 12/05/2001 | EP1159619A2 Methods of diagnosing and treating breast cancer |
| 12/05/2001 | EP1159445A1 Method to search for male antifertility drugs based on phgpx activity determination |
| 12/05/2001 | EP1159427A1 Gp120 mutants and biological applications |
| 12/05/2001 | EP1159426A1 CLONING AND EXPRESSION OF $i(HAEMOPHILUS SOMNUS) TRANSFERRIN-BINDING PROTEINS |
| 12/05/2001 | EP1159422A1 Compositions and methods for the treatment of tumors |
| 12/05/2001 | EP1159420A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides |
| 12/05/2001 | EP1159419A1 Promotion or inhibition of angiogenesis and cardiovascularization |
| 12/05/2001 | EP1159418A2 Muc-1 antagonists and methods of treating immune disorders |
| 12/05/2001 | EP1159417A2 Polynucleotides and proteins encoded thereby |
| 12/05/2001 | EP1159414A1 Process for enhancing electric field-mediated delivery of biological materials into cells |
| 12/05/2001 | EP1159412A2 Composition, methods and reagents for the synthesis of a soluble form of human phex |
| 12/05/2001 | EP1159408A2 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 12/05/2001 | EP1159300A2 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith |
| 12/05/2001 | EP1159298A1 Hiv peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by hiv |
| 12/05/2001 | EP1159297A2 Hiv related peptides |
| 12/05/2001 | EP1159286A1 Tumor necrosis factor receptors 6 alpha and 6 beta |
| 12/05/2001 | EP1159002A2 Emulsan and emulsan analogs immunization formulations and use |
| 12/05/2001 | EP1159001A2 MULTI-COMPONENT VACCINE COMPRISING AT LEAST THREE ANTIGENS TO PROTECT AGAINST DISEASE CAUSED BY $i(HAEMOPHILUS INFLUENZAE) |
| 12/05/2001 | EP1158999A2 Methods for improving graft acceptance in a recipient by administration of a cytokine profile altering agent |
| 12/05/2001 | EP1158993A1 Bacterial membrane fractions with adjuvant effect |
| 12/05/2001 | EP1158991A1 Treatment of asthma |
| 12/05/2001 | EP0783522B1 PEPTIDES FROM THE hPTH SEQUENCE (1-37) |
| 12/05/2001 | EP0769056B1 NON-SPLICING VARIANTS OF gp350/220 |
| 12/05/2001 | EP0763114B1 Hepatitis g virus and molecular cloning thereof |
| 12/05/2001 | EP0720484B1 Plant material for controlling immune responses in mammals and method for producing the material |
| 12/05/2001 | EP0605432B1 Induction of cytolytic t-lymphocytes with cytomegalovirus polypeptides |
| 12/05/2001 | CN1325441A Modified exosomes and uses |
| 12/05/2001 | CN1325407A Platelet-derived growth factor D, DNA coding therefor and uses thereof |
| 12/05/2001 | CN1325311A Vaccine against sexually transmitted diseases |
| 12/05/2001 | CN1324661A Human hepatitis B nucleic acid vaccine |
| 12/05/2001 | CN1324660A Static water pressure deactivation and nanometer techn. treatment process of influenza virus to prepare lytic vaccine |
| 12/04/2001 | USRE37462 Protein sequence of the plant toxin gelonin |
| 12/04/2001 | US6326465 Immunomodulatory polypeptides derived from the invariant chain of MHC class II |
| 12/04/2001 | US6326353 123therapy for septic shock; administering polymyxin by injection |
| 12/04/2001 | US6326350 Genetic engineering |
| 12/04/2001 | US6326207 Human sodium-dependent phosphate cotransporter |
| 12/04/2001 | US6326200 Isolated nona-and decapeptides which bind to HLA molecules, and the use thereof |
| 12/04/2001 | US6326181 Cell volume-regulated human kinase h-sgk |
| 12/04/2001 | US6326179 Enzymatic immunoglobulin; for use as therapeutic and diagnostic tools in treatment of arthritis, viral disease and alzheimer's disease |
| 12/04/2001 | US6326171 Hepatitis C E1 and E2 truncated polypeptides and methods of obtaining the same |
| 12/04/2001 | US6326162 Assays and peptide substrate for determining aggrecan degrading metallo protease activity |
| 12/04/2001 | US6326159 Receptors for immune complexes |
| 12/04/2001 | US6326141 Detecting pancreatic defect; evaluate humans for preferential gene expression, compare to healty human, amplified expression from preferential gene indicates pancreatic defect |
| 12/04/2001 | US6326009 Parenterally administering carbohydrate antigenic primer (determinant) bearing antigen; conjugated to animmunogenic carrier |
| 12/04/2001 | US6326008 Toxoplasma gondii antigens, the preparation thereof and the use thereof |
| 12/04/2001 | US6326007 Genes responsible for pathogenesis completely or partially nonfunctional by modifying or deleting nef (negative effector) start codon; enhanced expression of cytokine and/or lymphokine; vaccines |
| 12/04/2001 | US6326001 Recombinant vaccine for diseases caused by encapsulated organisms |
| 12/04/2001 | US6325999 Use of Fas ligand to suppress T-lymphocyte-mediated immune responses |
| 12/04/2001 | CA2218452C Novel ligands of the neuropeptide receptor hfgan72 |
| 12/04/2001 | CA2110703C Process and culture medium for the production of cells infected by a multiple sclerosis associated virus |
| 12/04/2001 | CA2053829C Vaccines against equine herpesviruses and the preparation thereof |
| 11/29/2001 | WO2001090421A2 Method of detecting inflammatory lung disorders |
| 11/29/2001 | WO2001090384A1 Viral vectors useful in induction of humoral or cellular immunity |
| 11/29/2001 | WO2001090371A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome) |
| 11/29/2001 | WO2001090363A1 Chimeric arterivirus-like particles |
| 11/29/2001 | WO2001090357A1 Compositions isolated from skin cells and methods for their use |
| 11/29/2001 | WO2001090330A2 AMINOACYL tRNA SYNTHETASES |
| 11/29/2001 | WO2001090191A2 ANTIBODIES CAPABLE TO SELECTIVELY DETECT PRION PrPSc ISOFORMS |
| 11/29/2001 | WO2001090185A2 Pt32 sperm protein, sperm c-yes, oocyte cytoplasmic c-yes, and uses thereof |
| 11/29/2001 | WO2001090182A2 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 11/29/2001 | WO2001090156A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
| 11/29/2001 | WO2001090155A2 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses |
| 11/29/2001 | WO2001090154A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 11/29/2001 | WO2001090152A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 11/29/2001 | WO2001090143A2 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions |
| 11/29/2001 | WO2001089568A1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 11/29/2001 | WO2001089566A1 Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy |
| 11/29/2001 | WO2001089564A2 Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity |
| 11/29/2001 | WO2001089563A1 Recombinant or purified polyclonal antibodies for treating allergy |
| 11/29/2001 | WO2001089562A1 F-protein epitope-based vaccine for respiratory syncytial virus infection |
| 11/29/2001 | WO2001089561A1 Aids vaccines |
| 11/29/2001 | WO2001089559A2 Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine |
| 11/29/2001 | WO2001089557A2 Methods for preventing strokes by inducing tolerance to e-selectin |
| 11/29/2001 | WO2001089549A2 Therapeutic uses of il-1 receptor antagonist |
| 11/29/2001 | WO2001089548A2 Pharmaceutical use of fibulin-1 |
| 11/29/2001 | WO2001089543A2 Use of proanthocyanidins as an active ingredient of a stimulator and l-arginine or its salts as a source of nitric oxide to relieve symptoms of erectile dysfuntion |
| 11/29/2001 | WO2001089535A1 Method for introducing and expressing genes in animal cells, and bacterial blebs for use in same |
| 11/29/2001 | WO2001089509A2 Method of treating hiv-1 disease |
| 11/29/2001 | WO2001089486A1 Nonoral preparation having three-layer structure |
| 11/29/2001 | WO2001089457A2 Thrombopoietin mimetics |
| 11/29/2001 | WO2001089456A2 Hybrid lt-a/ct-b holotoxin for use as an adjuvant |
| 11/29/2001 | WO2001089454A2 Proteus mirabilis-based vaccine |
| 11/29/2001 | WO2001089364A2 Hcv variants |
| 11/29/2001 | WO2001089361A2 Diagnosis, prevention and treatment of crohn's disease using the ompc antigen |
| 11/29/2001 | WO2001089286A2 T cell binding ligand peptides, peptide constructs containing same and use thereof for treatment of immunological disorders |
| 11/29/2001 | WO2001089281A2 Tumor-associated antigen (b132), characterized by seq. id. no. 2 |
| 11/29/2001 | WO2001062284A3 Novel method for down-regulation of amyloid |